Skip to main content
. Author manuscript; available in PMC: 2020 Nov 19.
Published in final edited form as: Urol Oncol. 2017 Sep 23;36(1):8.e17–8.e24. doi: 10.1016/j.urolonc.2017.08.027

Table 3:

Reclassification of risk of recurrence in 5122 patients with NMIBC assigned by EORTC categories and EAU categories

EAU Categories
Low-risk Intermediate-risk High-risk Total
EORTC Categories Low-risk 632 (100%) 0 0 632
Intermediate-risk 0 2302 (54.3%) 1940 (45.7%) 4242
High-risk 0 0 248 (100%) 248